Skip to main content

Table 2 The pathology scores of pancreases in each group on day 14 after treatment

From: Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models

Groups Edema (Mean ± SD) Necrosis (Mean ± SD) Inflammation (Mean ± SD) Hemorrhage (Mean ± SD) Total (Mean ± SD)
Group1 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.33 ± 0.52 0.33 ± 0.52
Group1’ 0.42 ± 0.20 * 0.50 ± 0.55 0.50 ± 0.55 * 0.17 ± 0.41 1.58 ± 0.80 *
Group2 0.08 ± 0.20 0.00 ± 0.00 0.17 ± 0.41 0.67 ± 0.52 0.92 ± 0.49
Group2’ 0.50 ± 0.32 * 0.17 ± 0.41 0.33 ± 0.52 0.00 ± 0.00 1.00 ± 0.63 *
Group3 0.13 ± 0.25 0.00 ± 0.00 1.00 ± 0.00 * 0.00 ± 0.00 1.13 ± 0.25 *
Group3’ 0.50 ± 0.00 * 0.00 ± 0.00 1.00 ± 0.00 * 0.33 ± 0.58 1.83 ± 0.58 *
Group4 0.38 ± 0.25 * 0.00 ± 0.00 0.25 ± 0.50 0.00 ± 0.00 0.63 ± 0.25
Group4’ 0.25 ± 0.29 0.00 ± 0.00 1.00 ± 0.00 * 0.00 ± 0.00 1.25 ± 0.29 *
  1. *P < 0.05, compared with group 1